Bandaram Pharma Packtech Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 0.76 | 3.80 | 2.63 |
Operating Expense | 1.03 | 3.75 | 2.58 |
Net Profit | -0.27 | 0.04 | 0.01 |
Net Profit Margin | -35.53 | 1.05 | 0.38 |
Earning Per Share | -0.22 | 0.04 | 0.01 |
EBIDTA | -0.27 | 0.05 | 0.04 |
Effective Tax Rate | TBA | 16.67 | 60 |
Particulars | Jun 2025 |
---|---|
Revenue | 0.76 |
Operating Expense | 1.03 |
Net Profit | -0.27 |
Net Profit Margin | -35.53 |
Earning Per Share | -0.22 |
EBIDTA | -0.27 |
Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 12.23 | 14.84 | 10.09 |
Operating Expenses Annual | 12.13 | 14.68 | 9.82 |
Operating Profit Annual | 0.19 | 0.19 | 0.27 |
Interest Annual | 0.00 | TBA | 0.00 |
Depreciation | 0.01 | 0.02 | 0.00 |
Net Profit Annual | 0.14 | 0.13 | 0.20 |
Tax Annual | 0.05 | 0.04 | 0.07 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 12.23 |
Operating Expenses Annual | 12.13 |
Operating Profit Annual | 0.19 |
Interest Annual | 0.00 |
Depreciation | 0.01 |
Net Profit Annual | 0.14 |
Tax Annual | 0.05 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 0.04 | 0.09 | 2.08 |
Cash Flow from Operations | -3.25 | -3.26 | -3.87 |
Cash Flow from Investing | TBA | -1.40 | -2.53 |
Cash Flow from Financing | 3.23 | 4.61 | 4.40 |
Cash Flow at the End | 0.02 | 0.04 | 0.09 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 0.04 |
Cash Flow from Operations | -3.25 |
Cash Flow from Investing | TBA |
Cash Flow from Financing | 3.23 |
Cash Flow at the End | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 1.55 | 1.28 | 2.68 |
PBIT Margin (%) | 1.47 | 1.15 | 2.68 |
PBT Margin (%) | 1.47 | 1.15 | 2.68 |
Net PROFIT Margin (%) | 1.14 | 0.88 | 1.98 |
Return On Networth / Equity (%) | 1.15 | 1.70 | 6.60 |
Return On Networth /Employed (%) | 1.37 | 1.73 | 5.16 |
Return On Assets (%) | 1.01 | 1.32 | 3.83 |
Total Debt / Equity (X) | 0.14 | 0.29 | 0.73 |
Asset Turnover Ratio (%) | 0.88 | 1.51 | 1.93 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 1.55 |
PBIT Margin (%) | 1.47 |
PBT Margin (%) | 1.47 |
Net PROFIT Margin (%) | 1.14 |
Return On Networth / Equity (%) | 1.15 |
Return On Networth /Employed (%) | 1.37 |
Return On Assets (%) | 1.01 |
Total Debt / Equity (X) | 0.14 |
Asset Turnover Ratio (%) | 0.88 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 0.00 | 0.01 | 0.02 |
Total Current Assets Annual | 12.62 | 9.43 | 5.74 |
Non Current Assets Annual | 6.59 | 3.92 | 2.53 |
Total Shareholders Funds Annual | 12.10 | 12.20 | 3.07 |
Total Assets Annual | 19.21 | 13.36 | 8.27 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 0.00 |
Total Current Assets Annual | 12.62 |
Non Current Assets Annual | 6.59 |
Total Shareholders Funds Annual | 12.10 |
Total Assets Annual | 19.21 |
EPS (INR)
Expected
0.02
Reported
0.02
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%